AhmedK.Y., VargheseZ., WillsM.R., MeinhardE., SkinnerR.K., BaillodR.A., and MoorheadJ.F..: Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy.Lancet2: 439, 1976.
3.
BoelensP.A., NorwoodW., KjellstrandC.M., and BrownD.M..: Hypophosphatemia with muscle weakness due to antacids and hemodialysis.Am. J. Dis. Child.120: 350, 1970.
4.
WhittierF.C., EvansD.H., AndersonP.C., and NolphK.D..: Peritoneal dialysis for psoriasis: A controlled study.Ann. Intern. Med.,99: 165, 1983.
5.
LentzR.D., BrownD.M., and KjellstrandC.M..: Treatment of severe hypophosphatemia.Ann. Intern. Med.89: 941, 1978.
6.
EbbenJ., StreifelA., DavinT., and KjellstrandC.M..: A system for adding poorly-soluble ions to dialysate.Dial. Transplant.11: 894, 1982.
7.
Technical bulletin on bicarbonate-buffered hemodialysis by B-D Drake Willock, a division of Becton Dickinson and Company, Portland, Oregon, U.S.A., edited by DymondD.D., and EastmanD.F.., 1980.
8.
PieridesA.M., EllisH.A., WardM.K., AljamaP., DewarJ., and KerrD.N.S..: The need and use of a phosphate-enriched dialysate during regular hemodialysis.Trans. Am. Soc. Artif. Intern. Organs23: 376, 1977.